Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,275 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06225648Recruiting
Threonine needs in older adults
This study measures how much threonine, an amino acid found in many foods, older adults need to stay healthy. Participants will follow a special diet for a short time and have blood tests.
Toronto, OntarioAges 60–90 - NCT07007065RecruitingPhase 3
Study of a gene therapy for wet age-related macular degeneration
This trial tests a one-time gene therapy injection for wet AMD that may reduce the need for regular eye injections. It is for people who have already responded to anti-VEGF injections but want a longer-lasting treatment.
Mesa, ArizonaAges 50 years+ - NCT06984510Recruiting
Early aging and diabetes risk with fatty liver
This study looks at how early biological aging might increase the chance of developing type 2 diabetes in people with a fatty liver (a condition called MASLD). It uses routine health check-up data to understand the link.
Ningbo, ZhejiangAges 20–90 - NCT05775484Recruiting
Exercise program to slow heart and blood vessel aging
This trial tests whether a structured exercise program can slow how quickly your cardiovascular system (heart and blood vessels) “ages” over time. If you’re able to move around outdoors safely, exercise may be a key part of the study.
Singapore, SingaporeAges 21–100 - NCT06912984Recruiting
How exercise affects blood vessels as we age
This study looks at how exercise changes blood vessels differently in older women and men. You'll be randomly assigned to either an exercise program or a no-exercise control group for a few months, and researchers will measure your blood vessel health before and after.
Aurora, ColoradoAges 18 years+ - NCT06956300Recruiting
TMS to help with thinking and memory in aging
This study uses a noninvasive brain stimulation technique called TMS to see if it can slow cognitive decline in older adults who are healthy or have very early signs of Alzheimer's disease. It aims to improve memory and thinking.
Boston, MassachusettsAges 40–99 - NCT06514547RecruitingPhase 4
Vaccine response and aging in people with HIV
This study is for people living with HIV who are 18 or older and on HIV medication. Researchers want to learn how the immune system and vaccine response change as people age, and will give a pneumococcal (pneumonia) vaccine to study that.
Minneapolis, MinnesotaAges 18 years+ - NCT06952452RecruitingPhase 3
Testing genes to improve AMD treatment
This trial studies how genes affect response to anti-VEGF injections for a common form of age-related vision loss (wet AMD). It aims to tailor treatment to each patient.
San Cristóbal de La Laguna, Santa Cruz De TenerifeAges 50 years+ - NCT06940037Recruiting
Aging biology and strength training in older adults
This study looks at how aging affects the way older adults respond to resistance training (exercises using weights or resistance bands). It compares two types of training to see which works better for improving mobility and strength.
Boston, MassachusettsAges 65 years+ - NCT06924021Recruiting
AMD Eye Image Library (ABID) Study
This study is creating a library of eye images to help doctors better diagnose age-related macular degeneration (AMD). You can join if you have healthy eyes or any stage of AMD that has never been treated.
Fargo, North DakotaAges 50 years+ - NCT06918704Recruiting
Digital brain health program for older adults
This study tests a digital program designed to help support thinking and memory in older adults. It may be a good fit if you are 60+ and generally healthy, even if you have some mild memory concerns.
San Francisco, CaliforniaAges 60–85 - NCT06794255Recruiting
Vitamin C for healthy aging in middle-aged adults
This study looks at whether vitamin C can help support healthy aging in middle-aged and older adults. It will compare taking vitamin C to a placebo (a dummy pill) to see if it improves overall health.
Nanchang, JiangxiAges 18–70 - NCT06857877Recruiting
Aging and brain health study in Tarrant County
This study looks at healthy aging by comparing memory and thinking in younger and older adults. If you join, you'll help researchers understand how aging affects the brain and may be part of a group that helps find ways to keep minds sharp as we get older.
Arlington, TexasAges 18–85 - NCT06844214RecruitingPhase 1/Phase 2
Gene therapy trial for myotonic dystrophy type 1
This trial tests a one-time gene therapy (SAR446268) for people with non-congenital myotonic dystrophy type 1. It aims to see if the treatment is safe and can improve muscle symptoms like stiffness and weakness.
Gainesville, FloridaAges 10–55 - NCT06229093Recruiting
Music study for healthy brain aging
This trial tests whether listening to specially designed music can help keep your brain healthy as you age. You'll listen to music at home and complete thinking and memory tasks to see if it makes a difference.
Boston, MassachusettsAges 18–95 - NCT06824285Recruiting
Brain wave markers in healthy aging
This study looks at how brain wave patterns change as people age normally, without any brain diseases. It may help researchers understand healthy aging better.
Rome, RomeAges 18 years+ - NCT06813261Recruiting
GLYLO supplement trial for aging in postmenopausal women
This trial tests whether a supplement called GLYLO can reduce markers of aging related to sugar damage in postmenopausal women. It may help if you are between 45 and 65, have some extra belly fat or higher blood sugar, and are not taking certain medications.
Novato, CaliforniaAges 45–65 - NCT06788379Recruiting
Testing a new marker for egg damage in women having IVF
This trial studies a protein called CENP-V to see if it can help measure egg (oocyte) health. It includes women at different ages and those using frozen eggs, to find better ways to predict egg quality.
Seville, SEVILLAAges 18–45 - NCT06765980RecruitingPhase 1/Phase 2
Study of KRIYA-825 for geographic atrophy in age-related macular degeneration
This trial tests an experimental drug called KRIYA-825 (also known as VV-14295) for people with geographic atrophy, a late stage of dry age-related macular degeneration that causes vision loss. The study aims to see if the treatment is safe and can help slow the progression of the disease.
Erie, PennsylvaniaAges 55–80 - NCT06738784Recruiting
Task analysis system for aging psychiatric patients living at home
This trial tests a system to help care teams better support adults over 40 with aging psychiatric disorders who live independently. The goal is to improve decisions about what kind of help and housing you need.
Bourdeaux, GirondeAges 40–65 - NCT06740266Recruiting
Parenting support for mothers and their babies
This study tests if a specially designed parenting program can help mothers and their babies bond better and possibly affect the baby's cells in a positive way. If you are a mother with a baby between 3 and 12 months old, receiving Medicaid, and getting care at WakeMed, you may be able to join.
Raleigh, North CarolinaAges 18 years+ - NCT06721143RecruitingPhase 1/Phase 2
Study of AION-301 for chronic kidney disease
This trial tests an experimental drug called AION-301 for people with chronic kidney disease (CKD). The goal is to see if it's safe and may help slow kidney decline. It's given by IV infusion and compared to a placebo (inactive infusion).
Miami, FloridaAges 35–75 - NCT06718010Recruiting
Blood markers and breast cancer treatment results
This study looks at how age-related changes in your blood might affect how well your breast cancer treatment works. It includes people with hormone receptor-positive, HER2-negative breast cancer that has not spread to distant organs.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06694272Recruiting
Visual function tests for early age-related macular degeneration
This study looks at how well the eyes function in people with early or intermediate age-related macular degeneration (AMD). It uses imaging and vision tests to help doctors better understand the condition.
ParisAges 18 years+
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,275 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.